Emilie Plantamura
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure.
Journal: Bone marrow transplantation
Published: December 01, 2025
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial.
Journal: EClinicalMedicine
Published: March 16, 2023
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients.
Journal: Nature communications
Published: September 25, 2020
MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 26, 2018
High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients.
Journal: Bone marrow transplantation
Published: April 03, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026